ACTU (STOCKS)
Actuate Therapeutics, Inc. Common stock
$2.050000
+0.030000 (+1.49%)
Prev close: $2.020000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Daniel M. Schmitt
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $49.05M
- Employees
- 10
- P/E (TTM)
- -2.04
- P/B (TTM)
- 12.66
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $299.11K |
| Operating Expenses | $21.84M |
| Research and Development | $9.64M |
| Other Operating Expenses | $12.20M |
| Operating Income/Loss | -$21.84M |
| Income/Loss From Continuing Operations After Tax | -$21.54M |
| Income/Loss From Continuing Operations Before Tax | -$21.54M |
| Net Income/Loss | -$21.54M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$21.54M |
| Net Income/Loss Available To Common Stockholders, Basic | -$21.54M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.97 |
| Diluted Earnings Per Share | -$0.97 |
| Basic Average Shares | 65,413,685 |
| Diluted Average Shares | 65,413,685 |
| Assets | $8.91M |
| Current Assets | $8.52M |
| Noncurrent Assets | $391.84K |
| Liabilities | $5.13M |
| Current Liabilities | $4.72M |
| Accounts Payable | $1.20M |
| Other Current Liabilities | $3.52M |
| Noncurrent Liabilities | $404.99K |
| Equity | $3.78M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $3.78M |
| Liabilities And Equity | $8.91M |
| Net Cash Flow From Operating Activities | -$19.60M |
| Net Cash Flow From Operating Activities, Continuing | -$19.60M |
| Net Cash Flow From Investing Activities | -$4.24M |
| Net Cash Flow From Investing Activities, Continuing | -$4.24M |
| Net Cash Flow From Financing Activities | $23.85M |
| Net Cash Flow From Financing Activities, Continuing | $23.85M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$21.54M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$21.54M |
| Other Comprehensive Income/Loss | $0.00 |